Table 5.
Estimates of the annual indirect costs of COPD in the US
| Study | Base year | Indirect cost measure | Study result | Value in 2010 USDa |
|---|---|---|---|---|
| Sin et al, 200210 | 1988–1994 | Productivity loss | $9.9 billion | $18.5 billion |
| Leigh et al, 200316 | 1999 | Lost earnings | $1.57 billion | $2.44 billion |
| Lost fringe benefits | $0.36 billion | $0.56 billion | ||
| Lost home earningsb | $0.21 billion | $0.33 billion | ||
| Total lost earnings and fringe benefits | $2.14 billion | $3.321 billion | ||
| Leigh et al, 200316 | 1999 | Morbidity | $1.26 billion | $1.957 billion |
| Mortality | $0.88 billion | $1.374 billion | ||
| Total morbidity and mortality | $2.14 billion | $3.321 billion | ||
| NHLBI, 20096 | Various | Projected 2010 morbidityc | $8.0 billion | $8.0 billion |
| NHLBI, 20121 | 2008 premature mortalityc | $14.8 billion | $15.0 billion |
Notes:
a
Study values were inflated to USD 2010 value using medical care component of the Consumer Price Index
b
lost productivity related to home tasks such as child care, home repair, meal preparation, etc
c
included for comparative purposes.
Abbreviations: COPD, chronic obstructive pulmonary disease; NHLBI, National Heart, Lung and Blood Institute; USD, US dollars.